children with hemophilia a treated with commercial factor viii concentrate had normal numbers of circulating t4+ lymphocytes and significantly increased numbers of circulating t8+ lymphocytes compared with their nontransfused age-matched counterparts .
C0019069
hemophilia a
C0015506
factor viii